Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mirabegron 25mg vs 50mg in Taiwanese OAB patients
NCT03044912Phase 3Unknown
- Sponsor
- Buddhist Tzu Chi General Hospital
- Start
- Nov 2015
- Primary completion
- Feb 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of mirabegron in overactive bladder syndrome (OAB), sponsored by Buddhist Tzu Chi General Hospital. Status: unknown.
02
Drugs
mirabegron
03
Conditions
overactive bladder syndrome (OAB)
Beyond the preview
Go deeper on NCT03044912.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03044912.